Neurotensin and CRH Interactions Augment Human Mast Cell Activation

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Alysandratos, Konstantinos Dionysios ^a,b,d,e   Asadi, Shahrzad ^a,c   Angelidou, Asimenia ^a,b,d,e   Zhang, Bodi ^a,d   Sismanopoulos, Nikolaos ^a,b,d   Yang, Hailing ^a   Critchfield, Agatha ^a   Theoharides, Theoharis C ^a,b,d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c TUFTS MEDICAL CENTER   (United States)

^d TUFTS UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MECLINERTANT; NEUROTENSIN; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE; GENE EXPRESSION; HORMONE BINDING; HUMAN; HUMAN CELL; IMMUNITY; MAST CELL ACTIVATION; MAST CELL DEGRANULATION; NTR GENE; PROTEIN EXPRESSION; PROTEIN SECRETION;

CELL DEGRANULATION; CORTICOTROPIN-RELEASING HORMONE; HUMANS; MAST CELLS; NEUROTENSIN; NF-KAPPA B; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, NEUROTENSIN; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RODENTIA;

EID: 84869128804     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048934     Document Type: Article

References (82)

1. Carraway R, Leeman SE, (1973) The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 248: 6854-6861.
2. Tyler-McMahon BM, Boules M, Richelson E, (2000) Neurotensin: peptide for the next millennium. Regul Pept 93: 125-136.
3. Mustain WC, Rychahou PG, Evers BM, (2011) The role of neurotensin in physiologic and pathologic processes. Curr Opin Endocrinol Diabetes Obes 18: 75-82.
4. Singh LK, Pang X, Alexacos N, Letourneau R, Theoharides TC, (1999) Acute immobilization stress triggers skin mast cell degranulation via corticotropin-releasing hormone, neurotensin and substance P: A link to neurogenic skin disorders. Brain Behav Immunity 13: 225-239.
5. Cochrane DE, Emigh C, Levine G, Carraway RE, Leeman SE, (1982) Neurotensin alters cutaneous vascular permeability and stimulates histamine release from isolated skin. Ann NY Acad Sci pp. 396-397.
6. Cochrane DE, Boucher W, Bibb P, (1986) Neurotensin stimulates histamine release in in vivo skin 'blisters' in rats: an effect inhibited by cromolyn or somatostatin. Int Arch Allergy Immunol 80: 225-230.
7. Carraway R, Cochrane DE, Lansman JB, Leeman SE, Paterson BM, et al. (1982) Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels. J Physiol 323: 403-414.
8. Feldberg RS, Cochrane DE, Carraway RE, Brown EB, Sawyer R, et al. (1998) Evidence for a neurotensin receptor in rat serosal mast cells. Inflamm Res 47: 245-250.
9. Barrocas AM, Cochrane DE, Carraway RE, Feldberg RS, (1999) Neurotensin stimulation of mast cell secretion is receptor-mediated, pertussis-toxin sensitive and requires activation of phospholipase C. Immunopharmacology. 41: 131-137.
10. Cochrane DE, Carraway RE, Boucher W, Feldberg RS, (1991) Rapid degradation of neutotensin by stimulated rat mast cells. Peptides 12: 1187-1194.
11. Donelan J, Boucher W, Papadopoulou N, Lytinas M, Papaliodis D, et al. (2006) Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci USA 103: 7759-7764.
12. Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, et al. (2010) Mast cells and inflammation. Biochim Biophys Acta 1822: 21-33.
13. Metz M, Maurer M, (2009) Innate immunity and allergy in the skin. Curr Opin Immunol 21: 687-693.
14. Galli SJ, Maurer M, Lantz CS, (1999) Mast cells as sentinels of innate immunity. Curr Opin Immunol 11: 53-59.
15. Kinet JP, (2007) The essential role of mast cells in orchestrating inflammation. Immunol Rev 217: 5-7.
16. Paus R, Theoharides TC, Arck PC, (2006) Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol 27: 32-39.
17. Theoharides TC, Cochrane DE, (2004) Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 146: 1-12.
18. Wright RJ, Cohen RT, Cohen S, (2005) The impact of stress on the development and expression of atopy. Curr Opin Allergy Clin Immunol 5: 23-29.
19. Slattery MJ, (2005) Psychiatric comorbidity associated with atopic disorders in children and adolescents. Immunol Allergy Clin North Am 25: 407-20, viii.
20. Stauder A, Kovacs M, (2003) Anxiety symptoms in allergic patients: identification and risk factors. Psychosom Med 65: 816-823.
21. Katsarou-Katsari A, Filippou A, Theoharides TC, (1999) Effect of stress and other psychological factors on the pathophysiology and treatment of dermatoses. Int J Immunopathol Pharmacol 12: 7-11.
22. Graham DT, Wolf S, (1953) The relation of eczema to attitude and to vascular reactions of the human skin. J Lab Clin Med 42: 238-254.
23. Linnet J, Jemec GB, (2001) Anxiety level and severity of skin condition predicts outcome of psychotherapy in atopic dermatitis patients. Int J Dermatol 40: 632-636.
24. Seiffert K, Hilbert E, Schaechinger H, Zouboulis CC, Deter HC, (2005) Psychophysiological reactivity under mental stress in atopic dermatitis. Dermatology 210: 286-293.
25. Sugiura H, Uehara M, (1993) Mitosis of mast cells in skin lesions of atopic dermatitis. Acta Derm Venereol (Stockh) 73: 296-299.
26. Rahman S, Collins M, Williams CM, Ma HL, (2011) The pathology and immunology of atopic dermatitis. Inflamm Allergy Drug Targets.
27. Stander S, Steinhoff M, (2002) Pathophysiology of pruritus in atopic dermatitis: an overview. Exp Dermatol 11: 12-24.
28. Bonness S, Bieber T, (2007) Molecular basis of atopic dermatitis. Curr Opin Allergy Clin Immunol 7: 382-386.
29. Bieber T, (2008) Atopic dermatitis. N Engl J Med 358: 1483-1494.
30. Damsgaard TE, Olesen AB, Srensen FB, Thestrup-Pedersen K, Schitz PO, (1997) Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin. Arch Dermatol Res 289: 256-260.
31. Sugiura H, Hirota Y, Uehara M, (1989) Heterogeneous distribution of mast cells in lichenified lesions of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 144: 115-118.
32. Jarvikallio A, Harvima IT, Naukkarinen A, (2003) Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 295: 2-7.
33. Ostlere LS, Cowen T, Rustin MH, (1995) Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol 20: 462-467.
34. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, et al. (1998) Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology 139: 403-413.
35. Crompton R, Clifton VL, Bisits AT, Read MA, Smith R, et al. (2003) Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways. J Clin Endocrinol Metab 88: 5427-5432.
36. Slominski A, Wortsman J, (2000) Neuroendocrinology of the skin. Endocr Rev 21: 457-487.
37. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, et al. (2003) Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 27: 677-682.
38. Sismanopoulos N, Delivani D, Alysandratos K-D, Angelidou A, Vasiadi M, et al. (2012) IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis. PloS One In press.
39. Kempuraj D, Saito H, Kaneko A, Fukagawa K, Nakayama M, et al. (1999) Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood 93: 3338-3346.
40. Li RCX, Ping P, Zhang J, Wead WB, Cao X, et al. (2001) PKCe modulates NF-kB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol 279: H1679-H1689.
41. Quevedo ME, Slominski A, Pinto W, Wei E, Wortsman J, (2001) Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell Dev Biol Anim 37: 50-54.
42. Cochrane DE, Carraway RE, Harrington K, Laudano M, Rawlings S, et al. (2011) HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1. Inflamm Res 60: 1139-1151.
43. Krüger PG, Aas P, Onarheim J, Helle KB, (1982) Neurotensin-induced release of histamine from rat mast cells in vitro. Acta Physiol Scand 114: 467-469.
44. Piliponsky AM, Chen CC, Nishimura T, Metz M, Rios EJ, et al. (2008) Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat Med 14: 392-398.
45. Asadi S, Alysandratos KD, Angelidou A, Miniati A, Sismanopoulos N, et al. (2012) Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast vells. J Invest Dermatol In press.
46. Ralph JA, Zocco D, Bresnihan B, FitzGerald O, McEvoy AN, et al. (2007) A role for type 1alpha corticotropin-releasing hormone receptors in mediating local changes in chronically inflamed tissue. Am J Pathol 170: 1121-1133.
47. Mousli M, Bueb J-L, Bronner C, Rouot B, Landry Y, (1990) G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. T I P S 11: 358-362.
48. Szekeres PG, Traynor JR, (1994) Direct activation of G proteins in membranes from SH-SY5Y human neuroblastoma cells by mastoparan and related peptides. Regul Pept 54: 293-294.
49. Mousli M, Bronner C, Landry Y, Bockaert J, Rouot B, (1990) Direct activation of GTP-binding regulatory proteins (G- proteins) by substance P and compound 48/80. FEBS Lett 259: 260-262.
50. Foreman JC, Jordan CC, Piotrowski W, (1982) Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skin. Br J Pharmacol 77: 531-539.
51. Gao GC, Wei ET, (1995) Inhibition of substance P-induced vascular leakage in rat by N-acetyl-neurotensin-(8-13). Regul Pept 58: 117-121.
52. Castagliuolo I, Wang C-C, Valenick L, Pasha A, Nikulasson S, et al. (1999) Neurotensin is a proinflammatory neuropeptide in colonic inflammation. J Clin Invest 103: 843-849.
53. Zhao D, Zhan Y, Zeng H, Koon HW, Moyer MP, et al. (2007) Neurotensin stimulates expression of early growth response gene-1 and EGF receptor through MAP kinase activation in human colonic epithelial cells. Int J Cancer 120: 1652-1656.
54. Zhao D, Bakirtzi K, Zhan Y, Zeng H, Koon HW, et al. (2011) Insulin-like growth factor-1 receptor transactivation modulates the inflammatory and proliferative responses of neurotensin in human colonic epithelial cells. J Biol Chem 286: 6092-6099.
55. Wang B, Parobchak N, Rosen T, (2012) RelB/NF-kappaB2 Regulates Corticotropin-Releasing Hormone in the Human Placenta. Mol Endocrinol 26: 1356-1369.
56. Chrousos GP, (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332: 1351-1362.
57. Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA, et al. (2001) Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 15: 1678-1693.
58. Slominski A, Pisarchik A, Tobin DJ, Mazurkiewicz J, Wortsman J, (2004) Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 145: 941-950.
59. Slominski A, Wortsman J, Luger T, Paus R, Solomon S, (2000) Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 80: 979-1020.
60. Lytinas M, Kempuraj D, Huang M, Boucher W, Esposito P, et al. (2003) Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists. Int Arch Allergy Immunol 130: 224-231.
61. Donelan J, Marchand J, Kempuraj D, Papadopoulou N, Theoharides TC, (2006) Perifollicular and perivascular mouse skin mast cells express corticotropin-releasing hormone receptor. J Inv Dermatol 126: 929-932.
62. Rozniecki JJ, Dimitriadou V, Lambracht-Hall M, Pang X, Theoharides TC, (1999) Morphological and functional demonstration of rat dura mast cell-neuron interactions in vitro and in vivo. Brain Res 849: 1-15.
63. Roloff B, Fechner K, Slominski A, Furkert J, Botchkarev VA, et al. (1998) Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J 12: 287-297.
64. Ito N, Sugawara K, Bodo E, Takigawa M, van BN, et al. (2010) Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme. J Invest Dermatol 130: 995-1004.
65. Slominski A, Ermak G, Mazurkiewicz JE, Baker J, Wortsman J, (1998) Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab 83: 1020-1024.
66. Karalis K, Louis JM, Bae D, Hilderbrand H, Majzoub JA, (1997) CRH and the immune system. J Neuroimmunol 72: 131-136.
67. Kempuraj D, Papadopoulou NG, Lytinas M, Huang M, Kandere-Grzybowska K, et al. (2004) Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology 145: 43-48.
68. Cao J, Papadopoulou N, Kempuraj D, Boucher WS, Sugimoto K, et al. (2005) Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 174: 7665-7675.
69. Grutzkau A, Kruger-Krasagakes S, Baumeister H, Schwarz C, Kogel H, et al. (1998) Synthesis, storage and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: Implications for the biological significance of VEGF206. Mol Biol Cell 9: 875-884.
70. Laham RJ, Li J, Tofukuji M, Post M, Simons M, et al. (2003) Spatial heterogeneity in VEGF-induced vasodilation: VEGF dilates microvessels but not epicardial and systemic arteries and veins. Ann Vasc Surg 17: 245-252.
71. Groneberg DA, Bester C, Grutzkau A, Serowka F, Fischer A, et al. (2005) Mast cells and vasculature in atopic dermatitis-potential stimulus of neoangiogenesis. Allergy 60: 90-97.
72. Oh SH, Park CO, Wu WH, Kim JY, Jin S, et al. (2012) Corticotropin-releasing hormone downregulates IL-10 production by adaptive forkhead box protein 3-negative regulatory T cells in patients with atopic dermatitis. J Allergy Clin Immunol 129: 151-159.
73. Kennedy NS, Barnstein B, Brenzovich J, Bailey DP, Kashyap M, et al. (2008) IL-10 suppresses mast cell IgE receptor expression and signaling in vitro and in vivo. J Immunol 180: 2848-2854.
74. Vasiadi M, Therianou A, Sideri K, Smyrnioti M, Delivani D, et al. (2012) Increased serum CRH levels with decreased skin CRH-R1 gene expression in psoriasis and atopic dermatitis. J Allergy Clin Immunol 129: 1410-3.
75. Metz M, Maurer M, (2007) Mast cells-key effector cells in immune responses. Trends Immunol 28: 234-241.
76. Weidinger S, Rummler L, Klopp N, Wagenpfeil S, Baurecht HJ, et al. (2005) Association study of mast cell chymase polymorphisms with atopy. Allergy 60: 1256-1261.
77. Badertscher K, Bronnimann M, Karlen S, Braathen LR, Yawalkar N, (2005) Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis. Arch Dermatol Res 296: 503-506.
78. Liu FT, Goodarzi H, Chen HY, (2011) IgE, Mast cells, and eosinophils in Atopic Dermatitis. Clin Rev Allergy Immunol.
79. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, et al. (2007) Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 217: 304-328.
80. Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, et al. (2004) Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci 25: 563-568.
81. Slominski A, (2009) On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders. Br J Dermatol 160: 229-232.
82. O'Kane M, Murphy EP, Kirby B, (2006) The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease. Exp Dermatol 15: 143-153.